Study guide
13.1 Retinal Neurophysiology & Electrophysiologic Origin of Waveforms
IJCAHPO Certified Ophthalmic Medical Technologist COMT
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The COMT Examination, Eligibility & Certification Requirements
1.1 The 190-Question Multiple-Choice Examination & the 22 Official Content Areas 1.2 The COT Skill Evaluation & the COMT Performance Test 1.3 Eligibility Pathways, Fees, Timelines & Recertification
2 Chapter 2: General Medical Knowledge I — Ocular Anatomy & Physiology
2.1 Orbit, Eyelids, Lacrimal System, Conjunctiva & Extraocular Muscles 2.2 Cornea, Sclera, Anterior Chamber, Angle, Aqueous Dynamics & Crystalline Lens 2.3 Uvea, Retina, Vitreous, Optic Nerve, Ocular Circulation & the Visual Pathway
3 Chapter 3: General Medical Knowledge II — Eye Disease, Systemic Manifestations, Terminology & Safety
3.1 Frequently Encountered Eye Conditions by Structure & Inflammation Versus Infection 3.2 Body Systems & the Ocular Manifestations of Systemic Disease 3.3 Medical Terminology, Approved Abbreviations, Hazardous Waste & Clinic Safety
4 Chapter 4: Ophthalmic History Taking & Clinical Documentation
4.1 The Five History Domains: Ocular, Medical, Medication, Social & Family 4.2 Charting Conventions, Scribing & the Electronic Medical Record
5 Chapter 5: Visual Assessment, Accommodative Testing & Low Vision
5.1 Measuring Acuity at Every Level & in Preliterate, Illiterate and Non-Verbal Patients 5.2 Stereoacuity, Near Point of Accommodation, Near Point of Convergence & the AC/A Ratio 5.3 Low Vision Assessment, Magnification Calculation & Device Instruction
6 Chapter 6: Tonometry, Keratometry & Pupil Measurement
6.1 Goldmann Applanation Tonometry: Technique, Sources of Error & the Imbert-Fick Principle 6.2 Hand-Held Applanators, Non-Contact Tonometry, Rebound Tonometry & Disinfection 6.3 Manual & Automated Keratometry: Technique, Readings and Interpretation 6.4 Pupil Measurement, Shape, Reactivity & Evaluating Anisocoria
7 Chapter 7: Lensometry, Spectacle Optics & Prescription Analysis
7.1 Manual Lensometry: Eyepiece Focus, Neutralising Sphere, Cylinder & Axis 7.2 Neutralising Reading Adds: Bifocal, Trifocal, Progressive & Determining the Near Add 7.3 Identifying & Measuring Prism: Ground-In, Decentration, Fresnel Press-On & Slab-Off 7.4 Transposition, Spherical Equivalent, Vertex Distance & Prescription Components 7.5 The Geneva Lens Clock, Lens Materials, Progressive Markings & Spectacle Adjustment
8 Chapter 8: Refraction, Retinoscopy & Refinement
8.1 Autorefraction, Refractive Error Types & Establishing an Objective Starting Point 8.2 Streak Retinoscopy: With Motion, Against Motion, Neutralisation & Working Distance 8.3 Subjective Refinement: Fogging, Jackson Cross Cylinder, Duochrome & Binocular Balance 8.4 Near Add Determination, Vertex Recording & Refraction in Difficult Situations
9 Chapter 9: Ocular Motility, Strabismus & Advanced Optics
9.1 Ocular Kinematics: Ductions, Versions, Vergences, Hering's & Sherrington's Laws 9.2 Quantitative Strabismus Measurements: Alternate Cover Test, Prism Cover Test & Lancaster Red-Green / Hess Screen 9.3 Cranial Nerve Palsies (CN III, IV, VI), Restrictive Myopathies & Forced Duction Testing 9.4 Clinical Optics, Prentice's Rule, Slab-Off Prisms & Wavefront Aberrations
10 Chapter 10: Sensory Fusion Testing, Nystagmus, Amblyopia & Vergence Therapy
10.1 Sensory Fusion Testing: Worth 4-Dot, Maddox Rod & Bagolini Lenses 10.2 Hirschberg, Krimsky, Brückner & Fusional Vergence Amplitudes 10.3 Nystagmus, Amblyopia Therapy & Convergence Training
11 Chapter 11: Advanced Visual Fields & Neuro-Ophthalmic Evaluation
11.1 Amsler Grid & Confrontation Visual Field Testing 11.2 Automated Static Perimetry: HFA Strategies (SITA Standard, SITA Fast), Reliability Indices & Statpac Analysis 11.3 Visual Field Defect Patterns: Glaucomatous Nerve Fiber Bundle Deficits vs. Retinal Pathology 11.4 Kinetic Perimetry (Goldmann Perimetry) & Neurological Visual Pathway Defect Localization 11.5 Pupillary Pathways, RAPD Quantitation with Neutral Density Filters & Pharmacologic Testing
12 Chapter 12: Supplemental Testing — Glare, PAM, Colour Vision, Tear Film & Slit Lamp Technique
12.1 Glare Testing, Potential Acuity Meter & Contrast Sensitivity 12.2 Colour Vision: Pseudoisochromatic Plates, Farnsworth-Munsell D-15 & the 100-Hue Test 12.3 Tear Film Assessment: Schirmer, Tear Break-Up Time, Vital Dyes & Corneal Sensitivity 12.4 Slit Lamp Technique, Slit Lamp Lenses, Direct Ophthalmoscopy & Pen Light Examination 12.5 Exophthalmometry, Head & Posture Assessment and Wavefront Diagnostics
13 Chapter 13: Full-Field Electroretinography & ISCEV Protocols
13.1 Retinal Neurophysiology & Electrophysiologic Origin of Waveforms 13.2 ISCEV Standard Full-Field ERG Protocol & Electrode Systems 13.3 Dark-Adapted (Scotopic) Testing: Rod-Driven Responses & Combined Maximal Response 13.4 Light-Adapted (Photopic) Testing: Cone Response, 30-Hz Flicker & Oscillatory Potentials
14 Chapter 14: Advanced Electrophysiologic Testing (mfERG, PERG, VEP, EOG)
14.1 Multifocal Electroretinogram (mfERG): Topographic Retinal Mapping 14.2 Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function 14.3 Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity 14.4 Electrooculogram (EOG), Arden Ratio & RPE Light Peak Dynamics
15 Chapter 15: Fluorescein Angiography Principles & Technique
15.1 Fluorescein Angiography Principles, Exciter/Barrier Filters & Injection Protocol 15.2 Normal Transit Phases & Retinal/Choroidal Circulation Hemodynamics 15.3 Adverse Reactions, Patient Safety & Emergency Management
16 Chapter 16: Angiographic Interpretation & Pathology
16.1 Hyperfluorescence Mechanisms: Leakage, Staining, Pooling, Window Defects & Autofluorescence 16.2 Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects 16.3 Indocyanine Green (ICG) Angiography: Principles, Indications & Choroidal Pathology
17 Chapter 17: Advanced Fundus Imaging & Optical Coherence Tomography
17.1 Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging 17.2 Spectral-Domain and Swept-Source OCT: Retinal Layer Architecture & Quantitative Analysis 17.3 Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT) 17.4 Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers
18 Chapter 18: Ophthalmic Photography & Videography
18.1 The Fundus Camera: Optics, Alignment & Correcting Artefacts 18.2 Standard Fundus Photography: ETDRS Fields, Stereo Pairs, Red-Free & Wide-Field Imaging 18.3 Slit Lamp & Anterior Segment Photography 18.4 External Photography, Nine-Gaze Motility Documentation & Image Management
19 Chapter 19: Ophthalmic Echography (A-Scan, B-Scan & UBM)
19.1 Physics of Ophthalmic Ultrasound, Acoustic Impedance & Probe Transducers 19.2 Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation 19.3 Diagnostic B-Scan Echography: Topographic, Kinetic & Quantitative Vitreoretinal Evaluation 19.4 Ultrasound Biomicroscopy (UBM): Anterior Segment Anatomy, Angle Pathology & Ciliary Body Imaging
20 Chapter 20: Biometry, Topography & Corneal Analysis
20.1 Optical Biometry vs. Immersion/Contact Ultrasound Biometry 20.2 Intraocular Lens (IOL) Power Calculation Formulas & Post-Refractive Adjustments 20.3 Corneal Topography, Scheimpflug Tomography & Keratoconus Screening 20.4 Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth
21 Chapter 21: Rigid Gas Permeable & Specialty Lens Fitting
21.1 Rigid Gas Permeable (RGP) Material Properties, Dk/t & Oxygen Permeability 21.2 RGP Base Curve Selection, Diagnostic Fitting & Fluorescein Pattern Evaluation 21.3 Scleral Contact Lens Design, Sagittal Depth Fitting & Clearance Evaluation 21.4 Keratoconus, Irregular Corneas & Hybrid Contact Lens Systems
22 Chapter 22: Toric, Multifocal, Therapeutic Lenses & Complications
22.1 Toric Soft Contact Lens Dynamics, Stabilization Techniques & LARS Rule 22.2 Presbyopic & Multifocal Contact Lens Systems: Simultaneous vs. Translating Designs 22.3 Therapeutic Bandage Contact Lenses, Amniotic Membranes & Orthokeratology 22.4 Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis
23 Chapter 23: Ocular Pharmacology
23.1 Routes of Drug Delivery, Prescription Components & Instillation Technique 23.2 Mydriatics, Cycloplegics, Anaesthetics & Diagnostic Agents 23.3 Glaucoma Medications: Classes, Mechanisms & Side Effects 23.4 Anti-Infectives, Corticosteroids, NSAIDs, Allergy Agents, Lubricants, Supplements & Anti-VEGF
24 Chapter 24: Microbiology & Ocular Specimen Collection
24.1 Types of Microorganisms & Pathways of Disease Transmission 24.2 Assisting with Conjunctival & Corneal Specimen Collection
25 Chapter 25: Anterior Segment, Glaucoma & Refractive Surgery
25.1 Advanced Phacoemulsification, Surgical Steps, Fluidics & Complication Management 25.2 Premium Intraocular Lenses: Toric, Multifocal, EDOF & Lens Exchange 25.3 Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices 25.4 Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs
26 Chapter 26: Vitreoretinal, Corneal & Trauma Surgery
26.1 Pars Plana Vitrectomy (PPV), Scleral Buckling & Intraocular Tamponades (Gas/Silicone Oil) 26.2 Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK) 26.3 Ocular Trauma Repair: Open Globe Management, Hyphema, Vitreous Loss & Endophthalmitis Protocol
27 Chapter 27: Surgical Asepsis, Instrumentation & Laser Procedures
27.1 Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions 27.2 Microsurgical Instrumentation, Maintenance & Sharps Safety 27.3 Ophthalmic Laser Physics, Delivery Systems & Safety (Nd:YAG, Argon/FD-Nd:YAG, SLT)
28 Chapter 28: Ophthalmic Patient Services & Education
28.1 Communicating with Patients, Families and Colleagues, and Handling Dissatisfaction 28.2 Patient Education & Counselling on Conditions, Medications, Tests and Results 28.3 Ophthalmic Emergencies, First Aid, Vital Signs & CPR 28.4 Triage, Urgency-Based Scheduling, Patient Flow & Telephone Management 28.5 Dressings and Shields, Prosthetics, Legal Forms, Referrals & Reimbursement Support
29 Chapter 29: Clinic Operations — Equipment Maintenance, Ethics, Coding & Compliance
29.1 Equipment Maintenance, Calibration, Emergency Equipment & Inventory 29.2 Confidentiality, Informed Consent, Scope of Practice & Ethical Standards 29.3 Coding, Scribing Compliance, Quality Assurance & Regulatory Requirements
13.1 Retinal Neurophysiology & Electrophysiologic Origin of Waveforms
Key Takeaways Explain This Topic AI
The full-field electroretinogram (ffERG) records the mass transretinal electrical response of the entire retina elicited by a brief, diffuse flash of light under defined states of retinal adaptation.
The initial cornea-negative a-wave (Granit's late PIII) originates directly from light-induced closure of cyclic nucleotide-gated (CNG) cation channels and the resulting hyperpolarization of rod and cone photoreceptor outer segments.
The cornea-positive b-wave (Granit's PII) is primarily generated by depolarizing ON-bipolar cells acting through mGluR6 receptors and TRPM1 channels, shaped by transretinal potassium (K⁺) spatial buffering currents traversing radial Müller glial cells.
Oscillatory potentials (OPs) are high-frequency wavelets (100–160 Hz) on the ascending limb of the b-wave generated by inhibitory feedback circuits among amacrine, interplexiform, and bipolar cells within the inner plexiform layer.
An electronegative ERG waveform (b-to-a amplitude ratio < 1.0) signifies selective middle/inner retinal transmission failure or inner retinal ischemia with preserved photoreceptors, classically seen in central retinal artery occlusion (CRAO), congenital stationary night blindness (CSNB), and X-linked juvenile retinoschisis (XLRS).
Last updated: September 2026
Retinal Neurophysiology & Electrophysiologic Origin of Waveforms
Core Clinical Mandate: The full-field electroretinogram (ffERG) is an objective, non-invasive electrophysiological test that measures the summated electrical activity of the entire neurosensory retina in response to diffuse light stimulation. For the Certified Ophthalmic Medical Technologist (COMT), mastering the cellular generators of each waveform component is essential for distinguishing outer retinal photoreceptor degenerations from inner retinal synaptic and ischemic pathologies.
1. Biophysical Foundations of the Transretinal Field Potential
The retina is an organized, laminated sensory neuroepithelium comprising five primary neuronal classes— photoreceptors , horizontal cells , bipolar cells , amacrine cells , and ganglion cells —along with specialized radial glial cells known as Müller cells . When a light flash impinges upon the dark- or light-adapted retina, light-driven ion fluxes across neuronal membranes generate extracellular electrical currents.
Because the cellular elements of the retina are aligned in a strict radial (perpendicular) orientation relative to the ocular coats, individual microscopic current loops summate along the radial axis of the eye. In accordance with Ohm's law ( V = I × R V = I \times R V = I × R ), these extracellular current loops flowing through the finite resistance of the intraretinal tissue, subretinal space, and ocular media produce a measurable electrical potential gradient between the anterior segment of the eye (the cornea) and the posterior pole (the sclera). An active recording electrode placed in contact with the cornea or lower conjunctival fornix registers these voltage fluctuations as a function of time relative to an indifferent reference electrode. Radial Current Flow Architecture:
[Corneal Electrode (+)] <--- Ocular Media <--- Neurosensory Retina <--- RPE / Sclera [Reference (-)]
It is clinically vital to recognize that the standard full-field ERG is a mass retinal response . Approximately 20% to 30% of the total retinal area must be dysfunctional before a noticeable reduction in full-field ERG amplitude occurs. Consequently, localized macular lesions—such as geographic atrophy, dense central macular holes, or disciform choroidal neovascular scars—yield a completely normal full-field ERG because the macula accounts for less than 5% of the total retinal surface area. Evaluating isolated macular dysfunction requires specialized modalities such as focal ERG or multifocal ERG (mfERG) .
2. The Phototransduction Cascade and Genesis of the a-Wave
The a-wave is the initial, cornea-negative deflection of the electroretinogram following flash onset. In historical physiological literature, it corresponds to Granit's late PIII component .
The Dark Current and Resting Membrane Potential
In complete darkness, photoreceptor outer segments maintain a continuous inward flow of cations ( N a + Na^+ N a + and C a 2 + Ca^{2+} C a 2 + ) through cyclic nucleotide-gated (CNG) cation channels. This constitutive inward positive current is termed the dark current :
High basal levels of intracellular cyclic guanosine monophosphate (cGMP) bind directly to the cytoplasmic domains of CNG channels, holding them in an open conformation.
Concurrently, K + K^+ K + ions continuously exit the inner segment through non-gated potassium channels, and an energy-consuming N a + / K + Na^+/K^+ N a + / K + ATPase pump in the inner segment membrane extrudes N a + Na^+ N a + while pumping in K + K^+ K + .
This steady circulating loop of current maintains the photoreceptor in a partially depolarized resting state (membrane potential approximately -40 mV ).
Because the cell is depolarized, voltage-gated L-type calcium channels at the photoreceptor synaptic terminal remain open, driving the continuous, tonic release of the neurotransmitter L-glutamate into the outer plexiform layer (OPL).
Light Activation and Hyperpolarization
When a photon strikes an opsin photopigment molecule (rhodopsin in rods, cone opsin in cones):
Photoisomerization: The chromophore 11-cis-retinal photoisomerizes within femtoseconds into all-trans-retinal .
G-Protein Activation: The conformational change activates opsin to its catalytically active state (metarhodopsin II), which binds the heterotrimeric G-protein transducin ( G t G_t G t ).
Effector Enzyme Stimulation: Transducin exchanges GDP for GTP, and its active α \alpha α -subunit dissociates to activate cGMP phosphodiesterase-6 (PDE6) .
cGMP Hydrolysis: Active PDE6 rapidly hydrolyzes cytosolic cGMP into 5'-GMP. Intracellular cGMP concentrations plummet within milliseconds.
Channel Closure: Deprived of bound cGMP, the outer segment CNG cation channels close abruptly , halting the inward dark current ( N a + Na^+ N a + and C a 2 + Ca^{2+} C a 2 + influx).
Membrane Hyperpolarization: Unopposed potassium efflux from the inner segment drives the photoreceptor membrane potential down toward the potassium equilibrium potential (approximately -70 mV ).
This light-induced reduction in positive charge influx into the outer segments creates an extracellular current sink in the outer retina and an extracellular source in the inner retina. The corneal recording electrode detects this rapid current withdrawal as a sharp negative voltage deflection—the ERG a-wave . Phototransduction Cascade:
- Photon Absorption --> 11-cis to all-trans retinal --> Transducin Activation
- -> PDE6 Activation --> cGMP Hydrolysis --> CNG Channel Closure
- -> Inward Dark Current Halts --> Photoreceptor Hyperpolarization (a-wave)
- Clinical Measurement of the a-Wave
Amplitude: Measured from the pre-stimulus baseline ( 0 μ V 0\ \mu\text{V} 0 μ V ) to the lowest negative trough of the deflection.
Implicit Time (Latency): Measured from the exact onset of the light flash ( t = 0 t = 0 t = 0 ) to the lowest negative trough of the a-wave. Under standard photopic conditions, implicit time is approximately 10 to 15 ms ; under dark-adapted maximal flash conditions, it ranges between 15 and 22 ms .
3. Synaptic Transmission and Genesis of the b-Wave
The b-wave is the prominent, cornea-positive deflection that follows the a-wave. It corresponds to Granit's PII component and represents the post-photoreceptor electrical activity of the inner nuclear layer.
Glutamatergic Synapses in the Outer Plexiform Layer
Photoreceptor hyperpolarization suppresses calcium influx at the synaptic terminal, causing an immediate drop in glutamate release into the synaptic cleft. Downstream second-order retinal neurons respond to this glutamate withdrawal according to the specific glutamate receptors they express:
Depolarizing (ON) Bipolar Cells:
Express metabotropic glutamate receptors ( mGluR6 ).
In darkness, high glutamate binds mGluR6, activating a G-protein ( G α o G_{\alpha o} G α o ) cascade that keeps the non-selective cation channel TRPM1 (transient receptor potential melastatin 1) tightly closed, keeping ON-bipolars hyperpolarized.
Following a light flash, the abrupt drop in extracellular glutamate relieves mGluR6 inhibition. TRPM1 channels spring open, permitting N a + Na^+ N a + and C a 2 + Ca^{2+} C a 2 + influx. The ON-bipolar cell depolarizes .
Hyperpolarizing (OFF) Bipolar Cells:
Express ionotropic AMPA and kainate receptors.
In darkness, glutamate opens these cation channels, keeping the cell depolarized.
Upon light-induced glutamate withdrawal, ionotropic channels close, and OFF-bipolar cells hyperpolarize .
Primary Cellular Generator of the b-Wave
Pharmacological dissection studies (utilizing 2-amino-4-phosphonobutyric acid, L-AP4 , which selectively agonizes mGluR6 receptors and blocks ON-bipolar cell responses) have definitively demonstrated that depolarizing ON-bipolar cells are the primary neuronal generators of the b-wave :
In scotopic (dark-adapted) rod-driven conditions, the b-wave is generated almost exclusively by rod ON-bipolar cells .
In photopic (light-adapted) cone-driven conditions, the b-wave reflects the combined activity of cone ON-bipolar cells (positive component) and cone OFF-bipolar cells (which shape the falling phase and trough).
Role of Radial Müller Glial Cells
Historically, the b-wave was attributed entirely to Müller cells —the principal radial glial elements spanning the full thickness of the retina from the inner limiting membrane (ILM) to the external limiting membrane (ELM). When depolarizing ON-bipolar cells become active, they extrude potassium ions ( K + K^+ K + ) into the confined extracellular space of the inner nuclear and outer plexiform layers:
Müller cells act as spatial buffers for excess extracellular K + K^+ K + , possessing high membrane densities of inwardly rectifying potassium channels ( Kir4.1 ).
The local elevation of [ K + ] o [K^+]_o [ K + ] o induces an influx of K + K^+ K + into the middle portion of the Müller cell and a compensatory efflux of K + K^+ K + at its endfoot near the vitreous and cornea.
This transretinal glial current loop shapes the temporal kinetics and voltage envelope of the b-wave. However, modern electrophysiology confirms that Müller cells act as passive contributors to the field potential, while ON-bipolar cells provide the active driving electromotive force .
Clinical Measurement of the b-Wave
Important
Critical Measurement Standard: The amplitude of the b-wave is ALWAYS measured from the trough of the a-wave to the peak of the b-wave , NOT from the pre-stimulus baseline. In waveforms where the a-wave is absent (such as the dim-flash DA 0.01 rod response), the b-wave amplitude is measured from the pre-stimulus baseline to the peak.
Implicit Time: Measured strictly from the onset of the light stimulus ( t = 0 t = 0 t = 0 ) to the maximum positive crest of the b-wave.
4. Genesis of Oscillatory Potentials (OPs)
Oscillatory potentials (OPs) are a series of 3 to 5 rhythmic, high-frequency, low-amplitude wavelets superimposed on the ascending limb of the b-wave.
Cellular Generators and Neurocircuitry
Frequency Band: High-frequency oscillations ranging between 100 Hz and 160 Hz .
Anatomical Locus: Inner plexiform layer (IPL) and inner nuclear layer (INL).
Neuronal Origin: Generated by complex reciprocal and feedforward inhibitory microcircuits between amacrine cells , interplexiform cells , and bipolar/ganglion cell synapses .
Neurochemistry: Modulated by inhibitory neurotransmitters, primarily gamma-aminobutyric acid (GABA) and glycine , along with dopaminergic interplexiform projections.
Vascular Vulnerability and Clinical Utility
Unlike the outer retinal photoreceptors (which receive metabolic support from the posterior ciliary and choroidal circulation), the inner plexiform layer and amacrine cells are supplied exclusively by the retinal microcirculation (branches of the central retinal artery):
Because of their high metabolic rate and location in the inner capillary plexus, oscillatory potentials are exquisitely sensitive to retinal hypoxia, ischemia, and microvascular hypoperfusion .
Attenuation or disappearance of OPs is an early clinical herald of ischemic retinal vascular disorders, most notably diabetic retinopathy , where OP loss precedes overt clinical microaneurysms and predicts progression to neovascularization.
5. Other Electroretinographic Components: c-Wave, d-Wave, and PhNR
Component Polarity & Timing Primary Cellular Generator Clinical Significance
a-wave (Late PIII) Cornea-negative; ~10–25 ms Photoreceptor outer segments (rod & cone hyperpolarization) Diagnoses rod/cone dystrophies, outer retinal degenerations
b-wave (PIII/PII) Cornea-positive; ~30–90 ms Depolarizing ON-bipolar cells (modulated by Müller glia) Evaluates inner nuclear layer integrity & synaptic transmission
Oscillatory Potentials Cornea-positive wavelets; 100–160 Hz Amacrine and interplexiform cells (inner plexiform layer) Earliest indicator of retinal ischemia & diabetic microangiopathy
c-wave Slow cornea-positive; peaks at 2–5 s Apical membrane of the retinal pigment epithelium (RPE) Reflects RPE-photoreceptor metabolic interaction (decreased subretinal [ K + ] [K^+] [ K + ] )
d-wave Cornea-positive "off-response" Hyperpolarizing OFF-bipolar and horizontal cells at light offset Evaluates cone OFF-pathway under long-duration photopic stimuli
Photopic Negative Response (PhNR) Slow cornea-negative after b-wave Retinal ganglion cells (RGCs) and their supporting astrocytes Sensitive biomarker for glaucomatous optic neuropathy & optic atrophy
6. The Electronegative ERG ("Negative ERG")
An electronegative ERG is one of the most clinically critical and pathognomonic patterns encountered in ophthalmic electrophysiology. It is defined by a profound, selective reduction or total extinction of the b-wave in the presence of a well-preserved, robust a-wave. Electronegative Waveform Criteria:
- Normal, deep a-wave (photoreceptors functional)
- Severely blunted or absent b-wave (inner retinal signaling lost)
- Result: b-to-a amplitude ratio is LESS THAN 1.0 (b/a < 1.0)
Under normal physiological conditions, the Dark-Adapted 3.0 combined maximal response exhibits a b-to-a amplitude ratio greater than 1.5 (typically 1.6 to 2.5). When the b-wave amplitude drops below the trough of the a-wave, the ratio falls below 1.0, and the overall waveform assumes an electronegative morphology.
Pathophysiological Principle
The dual blood supply of the retina provides the anatomical basis for understanding the electronegative ERG:
Outer Retina (Photoreceptors and RPE): Nourished by the choriocapillaris via the short posterior ciliary arteries.
Inner Retina (Bipolar, Amacrine, Ganglion, and Müller cells): Nourished by the central retinal artery (CRA) .
Any pathological insult that selectively spares the outer retina while destroying the inner nuclear layer, or any genetic defect that specifically interrupts synaptic transmission between photoreceptors and ON-bipolar cells, produces an electronegative ERG.
Differential Diagnosis of the Electronegative ERG
Clinical Entity Primary Genetic / Pathological Etiology Specific Site of Lesion Distinguishing Clinical Features
Central Retinal Artery Occlusion (CRAO) Acute thromboembolic occlusion of central retinal artery Inner retinal infarction (INL, IPL, GCL); outer retina spared by choroid Sudden painless vision loss, cherry-red spot, severe acute b-wave extinction
Congenital Stationary Night Blindness (CSNB1, Complete) Mutations in NYX (nyctalopin), GRM6 (mGluR6), or TRPM1 Disruption of depolarizing ON-bipolar cell signaling cascade Congenital night blindness, normal fundus, absent DA 0.01 rod response
Congenital Stationary Night Blindness (CSNB2, Incomplete) Mutations in CACNA1F (encodes Ca v 1.4 \text{Ca}_v1.4 Ca v 1.4 voltage-gated C a 2 + Ca^{2+} C a 2 + channel) Defective synaptic exocytosis at rod and cone terminals Night blindness, myopia, subnormal photopic responses, residual rod function
X-Linked Juvenile Retinoschisis (XLRS) Hemizygous mutations in RS1 (encodes retinoschisin) Disruption of cell-cell adhesion in inner nuclear and outer plexiform layers Foveal "spoke-wheel" schisis, peripheral schisis, young males, splitting at INL
Melanoma-Associated Retinopathy (MAR) Paraneoplastic autoantibodies targeting TRPM1 cation channels Selective autoimmune destruction of ON-bipolar cell cation channels Cutaneous melanoma history, acute shimmering photopsias, night blindness
Ocular Siderosis / Metallosis Bulbi Retained intraocular iron foreign body yielding hydroxyl free radicals Preferential toxic deposition in Müller glia and inner retinal neurons Progressive heterochromia, rust deposits, early b-wave loss progressing to flat ERG
Quinine Toxicity Overdose of cinchona alkaloid quinine (>1 g) Severe arteriolar spasm and direct inner retinal neurotoxicity Sudden blindness, fixed dilated pupils, profound b-wave extinction with normal a-wave
Tip
Technologist Board Tip: When examining an ERG showing a b / a b/a b / a ratio < 1.0 < 1.0 < 1.0 , immediately check the patient history for sudden visual loss (CRAO), lifelong night blindness with normal fundus (CSNB), pediatric vitreoretinal schisis in a male (XLRS), or a history of malignant melanoma (MAR). Identifying an electronegative configuration is one of the highest-yield diagnostic skills on the COMT examination.